← Back
$TARS All transactions

Tarsus Pharmaceuticals, Inc.

▼ SELL 10b5-1 Plan

$ Value

$74K

Shares

893

Price

$83

Filed

Jan 6

Insider

Name

Whitfield Dianne C.

Title

Chief Human Resources Officer

CIK

0001839516

Roles

Officer

Transaction Details

Transaction Date

2026-01-02

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

23,393

Footnotes

The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. | The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $79.42 to $80.40. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $80.42 to $81.29. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $81.68 to $82.62. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $82.82 to $83.32. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0001839516-26-000002

Form Type

4

Issuer CIK

0001819790

Whitfield Dianne C.'s History

Date Ticker Type Value
2026-01-02 TARS $458K
2026-01-02 TARS $656K
2026-01-02 TARS $68K
2026-01-02 TARS $74K
2025-12-16 TARS $592K

Other Insiders at TARS (90d)

Insider Bought Sold Last
Neervannan Seshadri
Chief Operating Officer
$200K 2026-03-20